FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ruth Wu-Wong

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Radioligand Assay

Co-author Network

Publications

TOP 3
J Ruth Wu-Wong; Masaki Nakane; Yung-Wu Chen
Mapping the time-dependent effects of paricalcitol on serum calcium, phosphorus and parathyroid hormone levels in 5/6 nephrectomized uremic rats.
J Ruth Wu-Wong; Jerry L Wessale; Meng-Ting Wu; Yung-Wu Chen; Ching-Jang Huang; Megumi Kawai; Masaki Nakane
Two novel vitamin d receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats.
J Ruth Wu-Wong; Yung-Wu Chen; Megumi Kawai; Masaki Nakane
VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ruth Wu-Wong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: J Ruth Wu-Wong; Masaki Nakane; Yung-Wu Chen
Mapping the time-dependent effects of paricalcitol on serum calcium, phosphorus and parathyroid hormone levels in 5/6 nephrectomized uremic rats.
Life sciences 2013;92(2):161-6.
2013: J Ruth Wu-Wong; Jerry L Wessale; Meng-Ting Wu; Yung-Wu Chen; Ching-Jang Huang; Megumi Kawai; Masaki Nakane
Two novel vitamin d receptor modulators with similar structures exhibit different hypercalcemic effects in 5/6 nephrectomized uremic rats.
American journal of nephrology 2013;37():310-9.
2011: J Ruth Wu-Wong; Yung-Wu Chen; Megumi Kawai; Masaki Nakane
VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects.
British journal of pharmacology 2011;164(2b):551-60.
2011: J Ruth Wu-Wong; Yung-Wu Chen; Masaki Nakane; Myles Wolf
Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2011;25(3):215-22.
2011: J Ruth Wu-Wong
Vitamin D therapy in cardiac hypertrophy and heart failure.
Current pharmaceutical design 2011;17(18):1794-807.
2010: J Ruth Wu-Wong; Masaki Nakane; Gerard D Gagne; Kristin A Brooks; William T Noonan
Comparison of the pharmacological effects of paricalcitol and doxercalciferol on the factors involved in mineral homeostasis.
International journal of endocrinology 2010;2010():621687.
2010: J Ruth Wu-Wong; William Noonan; Masaki Nakane; Kristin A Brooks; Jason A Segreti; James S Polakowski; Bryan Cox
Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats.
International journal of endocrinology 2010;2010():625852.
2009: J Ruth Wu-Wong
Are vitamin D receptor activators useful for the treatment of thrombosis?
Current opinion in investigational drugs (London, England : 2000) 2009;10(9):919-27.
2008: J Ruth Wu-Wong
Endothelial dysfunction and chronic kidney disease: treatment options.
Current opinion in investigational drugs (London, England : 2000) 2008;9(9):970-82.
2008: J Ruth Wu-Wong
American Society of Nephrology--40th Annual Conference (renal week 2007).
IDrugs : the investigational drugs journal 2008;11(1):30-2.
2007: J Ruth Wu-Wong; Masaki Nakane; Junli Ma; Xiaoan Ruan; Paul Kroeger
Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells.
American journal of physiology. Renal physiology 2007;293(5):F1592-604.
2007: Ryan M Fryer; Jason A Segreti; Deborah L Widomski; Pamela H Franklin; Patricia N Banfor; Kristin A Koch; Masaki Nakane; J Ruth Wu-Wong; Bryan Cox; Glenn A Reinhart
Systemic activation of the calcium sensing receptor produces acute effects on vascular tone and circulatory function in uremic and normal rats: focus on central versus peripheral control of vascular tone and blood pressure by cinacalcet.
The Journal of pharmacology and experimental therapeutics 2007;323(1):217-26.
2007: J Ruth Wu-Wong; Masaki Nakane; Junli Ma; Xiaoan Ruan; Paul Kroeger
VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.
Journal of cellular biochemistry 2007;100(6):1395-405.
2007: J Ruth Wu-Wong
The potential for vitamin D receptor activation in cardiovascular research.
Expert opinion on investigational drugs 2007;16(4):407-11.
2007: J Ruth Wu-Wong; Joel Melnick
Vascular calcification in chronic kidney failure: role of vitamin D receptor.
Current opinion in investigational drugs (London, England : 2000) 2007;8(3):237-47.
2007: Ryan M Fryer; Pamela A Rakestraw; Masaki Nakane; Doug Dixon; Patricia N Banfor; Kristin A Koch; J Ruth Wu-Wong; Glenn A Reinhart
Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice.
Nephron. Physiology 2007;106(4):p76-81.
2007: J Ruth Wu-Wong; Masaki Nakane; Junli Ma
Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells.
Journal of vascular research 2007;44(1):11-8.
2007: Masaki Nakane; Junli Ma; Andrew E Rose; Mark A Osinski; J Ruth Wu-Wong
Differential effects of Vitamin D analogs on calcium transport.
The Journal of steroid biochemistry and molecular biology 2007;103(1):84-9.
2006: J Ruth Wu-Wong; William Noonan; Junli Ma; Doug Dixon; Masaki Nakane; Antoinette L Bolin; Kristin A Koch; Steve P Postl; Sherry J Morgan; Glenn A Reinhart
Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification.
The Journal of pharmacology and experimental therapeutics 2006;318(1):90-8.
2006: J Ruth Wu-Wong; Masaki Nakane; Junli Ma; Xiaoan Ruan; Paul Kroeger
Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells.
Atherosclerosis 2006;186(1):20-8.
2006: J Ruth Wu-Wong; Masaki Nakane; Junli Ma; Doug Dixon; Gerard Gagne
Vitamin D receptor (VDR) localization in human promyelocytic leukemia cells.
Leukemia & lymphoma 2006;47(4):727-32.
2006: J Ruth Wu-Wong; Jin Tian; Masaki Nakane; Junli Ma; Thomas A Fey; Paul Kroeger; Ryan M Fryer; Glenn A Reinhart
Cardiovascular disease in chronic kidney failure: the role of VDR activators.
Current opinion in investigational drugs (London, England : 2000) 2006;7(3):206-13.
2006: J Ruth Wu-Wong; Masaki Nakane; Junli Ma
Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells.
Thrombosis research 2006;118(6):709-14.
2006: Masaki Nakane; Thomas A Fey; Douglas B Dixon; Junli Ma; Michael E Brune; Yan Chun Li; J Ruth Wu-Wong
Differential effects of Vitamin D analogs on bone formation and resorption.
The Journal of steroid biochemistry and molecular biology 2006;98(1):72-7.
2006: Mark G Anderson; Masaki Nakane; Xiaoan Ruan; Paul Kroeger; J Ruth Wu-Wong
Expression of VDR and CYP24A1 mRNA in human tumors.
Cancer chemotherapy and pharmacology 2006;57(2):234-40.
2005: J Ruth Wu-Wong; Masaki Nakane; Linda Traylor; Xiaoan Ruan; Paul Kroeger; Jin Tian
Cardiovascular disease in chronic kidney failure: is there a role for vitamin D analogs?
Current opinion in investigational drugs (London, England : 2000) 2005;6(3):245-54.
2004: J Ruth Wu-Wong; Jin Tian; David Goltzman
Vitamin D analogs as therapeutic agents: a clinical study update.
Current opinion in investigational drugs (London, England : 2000) 2004;5(3):320-6.
2003: Juan Juan Yin; Khalid S Mohammad; Sanna M Käkönen; Stephen E Harris; J Ruth Wu-Wong; Jerry L Wessale; Robert J Padley; I Ross Garrett; John M Chirgwin; Theresa A Guise
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(19):10954-9.
2002: J Ruth Wu-Wong
Endothelin receptor antagonists as therapeutic agents for cancer.
Current opinion in investigational drugs (London, England : 2000) 2002;3(8):1234-9.
2002: Robert J Padley; Douglas B Dixon; J Ruth Wu-Wong
Effect of castration on endothelin receptors.
Clinical science (London, England : 1979) 2002;103 Suppl 48():442S-445S.
2002: J Ruth Wu-Wong; Cathleen E Berg; Brian D Dayton
Endothelin-stimulated glucose uptake: effects of intracellular Ca(2+), cAMP and glucosamine.
Clinical science (London, England : 1979) 2002;103 Suppl 48():418S-423S.
2002: Bilal Ayach; John Tsang; Arco Y Jeng; André Blouin; Mélanie Gosselin; Fu-Hou Wang; J Ruth Wu-Wong; Jerry L Wessale; Terry J Opgenorth; Bruno Battistini
Effects of a selective endothelin A receptor antagonist, ABT-627, in healthy normotensive anaesthetized rats developing acute pulmonary air embolism.
Clinical science (London, England : 1979) 2002;103 Suppl 48():371S-375S.
2002: Mélanie Gosselin; Stéphanie Goulet; J Ruth Wu-Wong; Jerry L Wessale; Terry J Opgenorth; Louis-Philippe Boulet; Bruno Battistini
Effects of a selective ET(A)-receptor antagonist, atrasentan (ABT-627), in murine models of allergic asthma: demonstration of mouse strain specificity.
Clinical science (London, England : 1979) 2002;103 Suppl 48():367S-370S.
2002: Jerry L Wessale; Andrew L Adler; Eugene I Novosad; Samuel V Calzadilla; Brian D Dayton; Kennan Marsh; Martin Winn; Hwan-Soo Jae; Thomas W von Geldern; Terry J Opgenorth; J Ruth Wu-Wong
Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: ex vivo and in vivo studies.
Clinical science (London, England : 1979) 2002;103 Suppl 48():112S-117S.
2002: J Ruth Wu-Wong; Douglas B Dixon; William J Chiou; Bryan K Sorensen; Gang Liu; Hwan-Soo Jae; Andrew Tasker; Thomas W von Geldern; Martin Winn; Terry J Opgenorth
Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: in vitro studies.
Clinical science (London, England : 1979) 2002;103 Suppl 48():107S-111S.
2002: J Ruth Wu-Wong
S-0139 (Shionogi).
Current opinion in investigational drugs (London, England : 2000) 2002;3(7):1051-6.
2002: J Ruth Wu-Wong
Using receptor antagonists in binding studies to characterize a mammalian endothelin receptor.
Methods in molecular biology (Clifton, N.J.) 2002;206():71-91.
2002: J Ruth Wu-Wong
Characterization of a new endothelin receptor ligand by in vitro assays.
Methods in molecular biology (Clifton, N.J.) 2002;206():181-98.
2001: Bruce G Szczepankiewicz; Gang Liu; Hwan-Soo Jae; Andrew Tasker; IW Gunawardana; Thomas W von Geldern; Stephen L Gwaltney; J Ruth Wu-Wong; Laura Gehrke; William J Chiou; Robert B Credo; JD Alder; Michael A Nukkala; Nicolette A Zielinski; Ken Jarvis; Karl W Mollison; David Frost; Joy Bauch; Yu-Hua Hui; Akiyo Claiborne; Qun Li; Saul H Rosenberg
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models.
Journal of medicinal chemistry 2001;44(25):4416-30.
2001: Stephen K Tahir; Edward K Han; B Credo; Hwan-Soo Jae; Jennifer A Pietenpol; CD Scatena; J Ruth Wu-Wong; David Frost; Hing L Sham; Saul H Rosenberg; Shi-Chung Ng
A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Cancer research 2001;61(14):5480-5.
2001: J Ruth Wu-Wong
Sitaxsentan (ICOS-Texas Biotechnology).
Current opinion in investigational drugs (London, England : 2000) 2001;2(4):531-6.
2001: J Ruth Wu-Wong; JD Alder; L Alder; David J Burns; Edward K Han; B Credo; Stephen K Tahir; Brian D Dayton; PJ Ewing; William J Chiou
Identification and characterization of A-105972, an antineoplastic agent.
Cancer research 2001;61(4):1486-92.
2000: Terry J Opgenorth; Jerry L Wessale; Douglas B Dixon; Andrew L Adler; Samuel V Calzadilla; Robert J Padley; J Ruth Wu-Wong
Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level.
Journal of cardiovascular pharmacology 2000;36(5 Suppl 1):S292-6.
2000: J Ruth Wu-Wong; Cathleen E Berg; Deborah Kramer
Endothelin stimulates glucose uptake via activation of endothelin-A receptor in neonatal rat cardiomyocytes.
Journal of cardiovascular pharmacology 2000;36(5 Suppl 1):S179-83.
2000: J Wang; William J Chiou; Gerard Gagne; J Ruth Wu-Wong
Internalization of type-A endothelin receptor.
Journal of cardiovascular pharmacology 2000;36(5 Suppl 1):S61-5.
2000: William J Chiou; Jerry L Wessale; Thomas W von Geldern; Terry J Opgenorth; J Ruth Wu-Wong
'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effects.
Journal of cardiovascular pharmacology 2000;36(5 Suppl 1):S48-52.
2000: J Ruth Wu-Wong; William J Chiou; Jiahong Wang
Extracellular signal-regulated kinases are involved in the antiapoptotic effect of endothelin-1.
The Journal of pharmacology and experimental therapeutics 2000;293(2):514-21.
2000: Brian D Dayton; William J Chiou; Terry J Opgenorth; J Ruth Wu-Wong
Direct determination of endothelin receptor antagonist levels in plasma using a scintillation proximity assay.
Life sciences 2000;66(10):937-45.
1999: Steven A Boyd; Robert A Mantei; Andrew Tasker; Gang Liu; Bryan K Sorensen; KJ Henry; Thomas W von Geldern; Martin Winn; J Ruth Wu-Wong; William J Chiou; Douglas B Dixon; Charles W Hutchins; Kennan Marsh; Bach Nguyen; Terry J Opgenorth
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivity.
Bioorganic & medicinal chemistry 1999;7(6):991-1002.
1999: William J Chiou; Jieyi Wang; Cathleen E Berg; J Ruth Wu-Wong
SV40 virus transformation down-regulates endothelin receptor.
Biochimica et biophysica acta 1999;1450(1):35-44.
1999: J Ruth Wu-Wong; Cathleen E Berg; Jieyi Wang; William J Chiou; B Fissel
Endothelin stimulates glucose uptake and GLUT4 translocation via activation of endothelin ETA receptor in 3T3-L1 adipocytes.
The Journal of biological chemistry 1999;274(12):8103-10.
1999: J Ruth Wu-Wong; Douglas B Dixon; William J Chiou; Brian D Dayton; E I Novosad; Andrew L Adler; Jerry L Wessale; Samuel V Calzadilla; Lisa Hernandez; Kennan Marsh; Gang Liu; Bruce G Szczepankiewicz; Thomas W von Geldern; Terry J Opgenorth
Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor.
European journal of pharmacology 1999;366(2-3):189-201.
1998: Gang Liu; KJ Henry; Bruce G Szczepankiewicz; Martin Winn; N S Kozmina; Steven A Boyd; JT Wasicak; Thomas W von Geldern; J Ruth Wu-Wong; William J Chiou; Douglas B Dixon; Bach Nguyen; Kennan Marsh; Terry J Opgenorth
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546).
Journal of medicinal chemistry 1998;41(17):3261-75.
1998: Bruce G Szczepankiewicz; R B Bal; Thomas W von Geldern; J Ruth Wu-Wong; William J Chiou; Douglas B Dixon; Terry J Opgenorth; D J Hoffman; A J Borre; Kennan Marsh; B N Nguyen
The effects of diminishing albumin binding to some Endothelin receptor antagonists.
Life sciences 1998;63(21):1905-12.
1998: J Ruth Wu-Wong; Terry J Opgenorth
Endothelin and isoproterenol counter-regulate cAMP and mitogen-activated protein kinases.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S185-91.
1998: J Ruth Wu-Wong; Douglas B Dixon; Terry J Opgenorth
Effects of human plasma proteins on endothelin binding and function.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S164-8.
1997: J Ruth Wu-Wong; William J Chiou; Robert Dickinson; Terry J Opgenorth
Endothelin attenuates apoptosis in human smooth muscle cells.
The Biochemical journal 1997;328 ( Pt 3)():733-7.
1997: J Ruth Wu-Wong; Douglas B Dixon; William J Chiou; Terry J Opgenorth
Endothelin receptor antagonists: effect of serum albumin on potency and comparison of pharmacological characteristics.
The Journal of pharmacology and experimental therapeutics 1997;281(2):791-8.
1997: J Ruth Wu-Wong; William J Chiou; B Saeed; SR Magnuson; Brian D Dayton; Shi-Chung Ng; Terry J Opgenorth
Endothelin receptor in benign prostatic hyperplastic cells. Binding and functional studies.
Receptors & signal transduction 1997;7(3):165-75.
1997: William J Chiou; SR Magnuson; D Dixon; S Sundy; Terry J Opgenorth; J Ruth Wu-Wong
Dissociation characteristics of endothelin receptor agonists and antagonists in cloned human type-B endothelin receptor.
Endothelium : journal of endothelial cell research 1997;5(3):179-89.
1996: H M Rarick; T J Opgenorth; Thomas W von Geldern; J Ruth Wu-Wong; R John Solaro
An essential myosin light chain peptide induces supramaximal stimulation of cardiac myofibrillar ATPase activity.
The Journal of biological chemistry 1996;271(43):27039-43.
1996: J Ruth Wu-Wong; Brian D Dayton; Terry J Opgenorth
Endothelin-1-evoked arachidonic acid release: a Ca(2+)-dependent pathway.
The American journal of physiology 1996;271(3 Pt 1):C869-77.
1996: J Ruth Wu-Wong; W Chiou; S R Magnuson; B R Bianchi; Chun W Lin
Human astrocytoma U138MG cells express predominantly type-A endothelin receptor.
Biochimica et biophysica acta 1996;1311(3):155-63.
1996: Martin Winn; Thomas W von Geldern; Terry J Opgenorth; Hwan-Soo Jae; Andrew Tasker; Steven A Boyd; J A Kester; R A Mantei; R Bal; Bryan K Sorensen; J Ruth Wu-Wong; William J Chiou; Douglas B Dixon; E I Novosad; L Hernandez; Kennan Marsh
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
Journal of medicinal chemistry 1996;39(5):1039-48.
1996: Thomas W von Geldern; D J Hoffman; J A Kester; Hugh Nellans; Brian D Dayton; S V Calzadilla; Kennan Marsh; L Hernandez; W Chiou; Douglas B Dixon; J Ruth Wu-Wong; Terry J Opgenorth
Azole endothelin antagonists. 3. Using delta log P as a tool to improve absorption.
Journal of medicinal chemistry 1996;39(4):982-91.
1996: Thomas W von Geldern; J A Kester; R Bal; J Ruth Wu-Wong; W Chiou; Douglas B Dixon; Terry J Opgenorth
Azole endothelin antagonists. 2. Structure-activity studies.
Journal of medicinal chemistry 1996;39(4):968-81.
1996: Thomas W von Geldern; Charles W Hutchins; J A Kester; J Ruth Wu-Wong; W Chiou; Douglas B Dixon; Terry J Opgenorth
Azole endothelin antagonists. 1. A receptor model explains an unusual structure-activity profile.
Journal of medicinal chemistry 1996;39(4):957-67.
1996: Terry J Opgenorth; A L Adler; S V Calzadilla; William J Chiou; Brian D Dayton; Douglas B Dixon; L J Gehrke; L Hernandez; S R Magnuson; Kennan Marsh; E I Novosad; Thomas W von Geldern; Jerry L Wessale; Martin Winn; J Ruth Wu-Wong
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.
The Journal of pharmacology and experimental therapeutics 1996;276(2):473-81.
1996: J Ruth Wu-Wong; William J Chiou; D J Hoffman; Martin Winn; Thomas W von Geldern; Terry J Opgenorth
Endothelins and endothelin receptor antagonists: binding to plasma proteins.
Life sciences 1996;58(21):1839-47.
1995: J Ruth Wu-Wong; William J Chiou; S R Magnuson; Terry J Opgenorth
Endothelin receptor in human astrocytoma U373MG cells: binding, dissociation, receptor internalization.
The Journal of pharmacology and experimental therapeutics 1995;274(1):499-507.
1995: J Ruth Wu-Wong; William J Chiou; Douglas B Dixon; Terry J Opgenorth
Dissociation characteristics of endothelin ETA receptor agonists and antagonists.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S380-4.
1994: J Ruth Wu-Wong; William J Chiou; S R Magnuson; Terry J Opgenorth
Endothelin receptor agonists and antagonists exhibit different dissociation characteristics.
Biochimica et biophysica acta 1994;1224(2):288-94.
1994: J Ruth Wu-Wong; William J Chiou; Z J Huang; M J Vidal; Terry J Opgenorth
Endothelin receptors in human smooth muscle cells: antagonist potency differs on agonist-evoked responses.
The American journal of physiology 1994;267(5 Pt 1):C1185-95.
1994: William J Chiou; K Shiosaki; Andrew Tasker; J Ruth Wu-Wong
Characterization of two endothelin converting enzymes and their preference for big endothelin-1 and -2 as substrates.
Life sciences 1994;54(21):1613-9.
1994: J Ruth Wu-Wong; William J Chiou; K E Naugles; Terry J Opgenorth
Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist.
Life sciences 1994;54(22):1727-34.
1993: J Ruth Wu-Wong; William J Chiou; Terry J Opgenorth
Phosphoramidon modulates the number of endothelin receptors in cultured Swiss 3T3 fibroblasts.
Molecular pharmacology 1993;44(2):422-9.
1993: J Ruth Wu-Wong; W Chiou; S R Magnuson; David G Witte; Chun W Lin
Identification and characterization of type A endothelin receptors in MMQ cells.
Molecular pharmacology 1993;44(2):285-91.
1993: K Shiosaki; Andrew Tasker; G M Sullivan; Bryan K Sorensen; Thomas W von Geldern; J Ruth Wu-Wong; C A Marselle; Terry J Opgenorth
Potent and selective inhibitors of an aspartyl protease-like endothelin converting enzyme identified in rat lung.
Journal of medicinal chemistry 1993;36(4):468-78.
1993: J Ruth Wu-Wong; William J Chiou; Terry J Opgenorth
Prolonged treatment by phosphoramidon modulates the number of endothelin receptors in cultured Swiss 3T3 fibroblasts.
Journal of cardiovascular pharmacology 1993;22 Suppl 8():S77-80.
1992: Terry J Opgenorth; J Ruth Wu-Wong; K Shiosaki
Endothelin-converting enzymes.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1992;6(9):2653-9.
1991: J Ruth Wu-Wong; E M Devine; G P Budzik; Terry J Opgenorth
Characterization and partial purification of endothelin-converting enzyme in rat lung.
Journal of cardiovascular pharmacology 1991;17 Suppl 7():S20-5.
1990: J Ruth Wu-Wong; G P Budzik; E M Devine; Terry J Opgenorth
Characterization of endothelin converting enzyme in rat lung.
Biochemical and biophysical research communications 1990;171(3):1291-6.